These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15588742)

  • 21. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
    Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
    Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction.
    Wiviott SD; Morrow DA; Frederick PD; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2006 Apr; 47(8):1553-8. PubMed ID: 16630990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
    Kang S; Yang Y; Li CJ; Gao R
    Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Magnesium sulfate in acute myocardial infarction].
    Balli E; Giomi A; Del Citerna F
    G Ital Cardiol; 1995 Nov; 25(11):1425-32. PubMed ID: 8682239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous coronary intervention and 1 year survival in patients treated with fibrinolytic therapy for acute ST-elevation myocardial infarction.
    McClelland AJ; Owens CG; Walsh SJ; McCarty D; Mathew T; Stevenson M; Gracey H; Khan MM; Adgey AA
    Eur Heart J; 2005 Mar; 26(6):544-8. PubMed ID: 15713694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High mortality with ST elevation myocardial infarction in a nontrial setting.
    Shufelt KA; Paradiso-Hardy FL; Papastergiou J; Cohen EA
    Can J Cardiol; 2004 Dec; 20(14):1455-9. PubMed ID: 15614341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction.
    Patel MR; Meine TJ; Lindblad L; Griffin J; Granger CB; Becker RC; Van de Werf F; White H; Califf RM; Harrington RA
    Am Heart J; 2006 Feb; 151(2):316-22. PubMed ID: 16442893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Dudek D; Sardella G; Marino P; Chevalier B; Zijlstra F
    Eur Heart J; 2008 Dec; 29(24):3002-10. PubMed ID: 18775918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
    Tebbe U; Messer C; Stammwitz E; The GS; Dietl J; Bischoff KO; Schulten-Baumer U; Tebbenjohanns J; Gohlke H; Bramlage P;
    Dtsch Med Wochenschr; 2007 Jul; 132(30):1559-66. PubMed ID: 17628839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
    Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
    Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short- and long-term mortality in patients with ST-elevation myocardial infarction treated with different therapeutic strategies. Results from WIelkopolska REgional 2002 Registry (WIRE Registry).
    Grajek S; Lesiak M; Araszkiewicz A; Pyda M; Skorupski W; Grygier M; Mitkowski P; Prech M; Baszko A; Janus M; Breborowicz P; Rzeźniczak J; Tarchalski J; Główka A; Cieśliński A
    Kardiol Pol; 2008 Feb; 66(2):154-63; discussion 164-5. PubMed ID: 18344153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Lev EI; Kornowski R; Vaknin-Assa H; Porter A; Teplitsky I; Ben-Dor I; Brosh D; Fuchs S; Battler A; Assali A
    Am J Cardiol; 2008 Jul; 102(1):6-11. PubMed ID: 18572028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.